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Experimental Section：
Materials:ZrCl 4 was purchased from Bellingwell (Beijing, China) and 2-aminoterephthalic acid was purchased from Shanghai Siyu (Shanghai, China).
Adenine, chitosan, cesium carbonate, potassium antimony tartrate, ascorbic acid, ammonium heptamolybdate and adenosine triphosphate (ATP) were purchased from Macklin (Shanghai, China).BSAprotein,pyrrole, 4-formylbenzoic acid, L-cysteine Acid,glutathione and MTT were purchased from Sigma-Aldrich (Shanghai, China).
Other related inorganic compounds:MgSO 4 , CaCO 3 , Al(OH) 3 , Na 3 PO 4 , Na 2 HPO 4 , NaH 2 PO 4 , Na 2 SO 4 , Na 2 CO 3 , NaHCO 3 , NaHSO 3 , NaCl, etc. were purchased from Sinopharm (Shanghai, China). Analytical grades of all other chemical reagents were used directly without further purification. Ultrapure water (18.2 MΩ·cm) was obtained from a Water Pro water purification system (Labconco Corp., Kansas City, MO).
Instruments:
The FT-IRspectra were determined on a Nicolet Magna 750 FT-IR spectrometer. Transmission electron micrographs and scanning electron micrographs were obtained using a HITACHI HT7700 electron microscope and a SUPRA 55 electron microscope, respectively. Powder X-ray diffraction patterns were measured at room temperature (298K) on aD8 ADVANCE X-ray powder diffractometer. UV-visible absorption was measured on a TU-1900 dual beam UV-Vis spectrophotometer.
Dynamic light scattering (DLS) and Zeta potentials of the MOF material were obtained on a Malvern instruments Nano-ZS90. The fluorescence spectra were obtained with a spectrofluorometer with a xenon lamp (FLS-920, Edingburgh). In the MTT assay, the absorbance was measured in a microplate reader (Synergy 2, Biotek, USA), and S5 thesamples were measured for phosphorus content using a Thermo Fisher ICP 7000 emission spectrometer. The fluorescence imaging of mouse living and kidney organs was obtained using a Caliper IVIS Lumina Series III small animal in vivo imager. The fourparameters of kidney function in mouse blood were determined by an automatic biochemical analyzer (Qilu Medical Laboratory, Jinan, China). All pH measurements were performed using a pH-3c digital pH meter (Shanghai Leici, China) and a glass calomel electrode combination.
Synthesis of H 2 TCPP:5,10,15,20-tetrakis(4-carboxyphenyl)porphyrinwassynthesized according to previousliterature. S1 First, 4-formylbenzoicacid(3.0 g, 0.02 mol) was dissolvedinto themixture of propionic acid (200 mL) and pyrrole (1.39 mL, 0.02 mol).
Next, the mixture washeated to reflux for 1 h followed by cooling with the formation of brown-purpleprecipitate. The precipitate was isolated by filtration, washed with CH 2 Cl 2 for 3 times, and then dried under vacuum for 6 h. precipitate.Afterwards, the product was washed three times with DMF and then well dispersed in 50 mL of DMF for 12 hours. The solid product that not dissolved in DMF was centrifuged and collected to thoroughly disperse in 50 mL of ethanol for 24 hours.
Synthesis of the
The final product was washed with ethanol for 3 times and dried in a vacuum oven for 12 hours.
Synthesis of the BSA-MOFs:50 mg of the MOFs material was sufficiently dissolved in 100 ml H 2 O, followed by addition of 250 μL of glutaraldehyde (25%, 1:4). The reaction was stirred at 30 ℃ for 1 h and centrifuged at 10,000 rpm for 5 min. The product was re-dissolved completely in 100 mLH 2 O and added with 10 mg of BSA for 2 h at 30 ℃. The product was collected by centrifugation at 10,000 rpm for 5 min and freeze-dried at low temperature.
Cytotoxicity Test: HL-7702 cells harvested at log phase were seeded at a density of 5 × 10 4 cells/well in 96-well microtiter plates and incubated in DMEM at 37 °C, 5% shaken. Finally, the plate was shaken for 10 min to dissolve the formazan crystals.
Absorbance was measured at 490 nm with a microplate reader. 
Explore the Effect of Reducing
Study on Effect of Rat Serum Phosphorus Reduction in vitro:
4 mL of wistar rat heart blood was allowed to stand at room temperature for 10 min and centrifuged at 3,500 rpm for 10 min. Upper serum is diluted 10 times. The control group, the group 1 & 2 each took 2 mL of the above serum dilution solution, then 1 mg of the MOFs was added to the group 1, and 1 mg of MOFs material modified with the BSA protein was added to the group 2. The samples were incubated for 4 h in aincubator at 30°C
and centrifuged for 5 min at 10,000 rpm. 1 ml of upper serum is diluted 10 times. The three groups of samples'phosphorus content were measured by ICP 7000 emission spectrometer and phosphorus molybdenum blue spectrophotometry. Evaluation of Blood Phosphate Levels Treated by MOFs:Each mouse was bled with 0.2 mL of blood and kept for 10 min followed by centrifugation at 3,500 rpm for 10 min, and 20 μL of upper serum was sampled. Serum samplesin the normal group, the model group, and the treated group were collected with 40 μL per group (Each group of serum samples provided by two mice). Three groups of serum samples were collected three times in parallel. By diluting 25 times with H 2 O, 0.25 mL of the serum diluentwas again diluted 40 times and the phosphorus levels were determined by ICP 7000 emission spectrometer. Finally, 1 mL of serum diluent was characterized by the blood institution for the four indicators of renal function.
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